The Limb Salvage Center

Filter Your Results




Financing Will Advance Development of Shockwave Medical’s Lithoplasty Treatment

November 22, 2016 -- Shockwave Medical, a developer of treatments for calcified cardiovascular disease, announced the closing of $45 million in Series C financing led by Secto…

Understanding Clinical Data and Its Application to Clinical Practice

Krishna Rocha-Singh, MD

November 2016—The emphasis on evidence-based medical practice emerged in response to the potential hazards and inconsistencies of empirical clinical decision making and reinforced the impor…

LimFlow System for Percutaneous Treatment of End-Stage CLI Receives CE Mark

November 15, 2016 -- LimFlow SA announced today it has received CE Mark approval for its fully percutaneous LimFlow System designed for venous arterialization of the lower lim…

Global DISRUPT PAD III Trial Will Evaluate Shockwave Medical’s Lithoplasty System Combined With DCB Therapy in Calcified PAD

November 1, 2016 -- Shockwave Medical announced plans for the DISRUPT PAD III multicenter randomized trial that will exclusively enroll patients with calcified peripheral arte…

SoundBite Medical Solutions Announces New Funding for CTO Technology

October 31, 2016 -- SoundBite Medical Solutions Inc. (SBMS), a Quebec-based cardiovascular medical technology company, announced the third closing of a seed equity r…

ILLUMENATE Pivotal Trial Results Presented for Spectranetics’ Stellarex Drug-Coated Balloon

November 2, 2016 -- The Spectranetics Corporation announced that the final 12-month results of the ILLUMENATE pivotal trial for the company’s Stellarex drug-coated …

Spectranetics’ Stellarex DCB Takes Another Step Toward United States Market Approval With PMA Submission

November 2, 2016 -- The Spectranetics Corporation announced it has submitted the premarket approval (PMA) application to the US Food and Drug Administration for its Stellarex …

Intact Vascular’s TOBA II BTK Pivotal IDE Study Approved by FDA

October 31, 2016 -- Intact Vascular, Inc. announced that the US Food and Drug Administration (FDA) granted staged approval for the company’s investigational device …




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.